SPAC vs IPO Board Independence Requirements: Key Differences

The SEC’s March 2025 Staff Legal Bulletin on de-SPAC transactions has sharpened a long-overlooked structural difference: board independence requirements apply at different stages and with different stringencies for a traditional IPO versus a business combination with a special purpose acquisition company. For Hong Kong-based issuers and sponsors evaluating a US listing, this distinction carries material implications for director recruitment timelines, governance costs, and risk of SEC comment letters. A company pursuing a traditional IPO on NASDAQ must assemble a fully independent audit committee—defined under NASDAQ Listing Rule 5605(c)(2) as comprising at least three directors meeting heightened independence criteria—before filing its S-1. A SPAC target, by contrast, often inherits a board that was compliant at the time of the SPAC’s IPO but may fail independence tests post-combination if the target’s management dominates the new board. The 2025 Bulletin explicitly flagged this mismatch, requiring targets to demonstrate board compliance at the time of the proxy statement filing, not merely at closing.

The Regulatory Framework: NASDAQ and NYSE Board Independence Rules

NASDAQ’s Bright-Line Independence Tests

NASDAQ Listing Rule 5605(a)(2) defines an independent director as one who has no material relationship with the listed company, either directly or as a partner, shareholder, or officer of an entity that has a relationship with the company. The rule imposes a three-year cooling-off period for former employees, auditors, and certain family members. For audit committee members, NASDAQ Rule 5605(c)(2)(A) adds a prohibition on accepting any consulting, advisory, or compensatory fee from the company—a stricter standard than for general board independence. As of Q2 2025, NASDAQ had issued 14 deficiency notices to SPACs for audit committee composition failures post-de-SPAC, according to data compiled by the NYSE Governance Services database.

NYSE’s Comparable but Distinct Requirements

NYSE Listed Company Manual Section 303A.01 requires a majority of independent directors, with Section 303A.06 mandating a fully independent audit committee of at least three members. The NYSE applies a five-year cooling-off period for certain relationships, two years longer than NASDAQ’s baseline. For SPACs listing on the NYSE, the exchange issued a Staff Interpretation in November 2024 clarifying that the independence of directors appointed by the SPAC sponsor must be reassessed at the time of the business combination vote, not at the SPAC’s IPO. This interpretation directly responded to a pattern where sponsors placed affiliates on the board pre-IPO and retained them through the de-SPAC process.

SPAC Board Independence: The Pre-Combination Compliance Gap

The SPAC IPO Board Composition

A SPAC typically lists with a board that satisfies NASDAQ or NYSE independence rules at the time of its IPO. The SEC’s 2025 Bulletin cited data showing that 87% of SPACs listed between 2021 and 2024 had audit committees comprising three independent directors at IPO. However, the Bulletin noted a critical gap: the independence of those directors is assessed against the SPAC itself—a shell with no operating business. Relationships that would be disqualifying for an operating company—such as a director’s equity stake in the sponsor—are permissible for a SPAC board because the SPAC has no other material relationships.

The De-SPAC Independence Reassessment

When a SPAC identifies a target, the board must be reconstituted to comply with independence rules as applied to the combined entity. This reassessment frequently reveals conflicts that were invisible during the SPAC’s shell phase. A director who served as a partner at the sponsor’s law firm may be independent from the SPAC but not from the target, which may have retained that same firm for legal work. The 2025 Bulletin requires the target to file a board independence analysis with the proxy statement, including a description of each director’s relationships with the target, the sponsor, and the combined entity. Failure to do so has resulted in at least three SEC comment letters in 2025 demanding additional disclosure.

Traditional IPO Board Independence: Front-Loaded Compliance

Pre-Filing Audit Committee Formation

For a traditional IPO, the issuer must have a fully compliant audit committee in place before the S-1 is filed. NASDAQ Rule 5605(c)(2) requires that the audit committee include at least one member who is a “financial expert” as defined under Item 407(d)(5) of Regulation S-K. This requirement forces issuers to recruit independent directors with specific financial credentials months before the filing date. Data from the IPO tracking service of Dealogic shows that the median traditional IPO in 2024 added its first independent director 14 months before the effective date, compared to 6 months for SPAC targets.

The Compensation Committee and Nomination Committee Requirements

NASDAQ Rule 5605(d) requires that director nominees be selected, or recommended for the board’s selection, either by a majority of independent directors or by a nominating committee composed entirely of independent directors. Similarly, Rule 5605(e) requires that CEO compensation be determined by a compensation committee of independent directors. For a traditional IPO, these committees must be operational at the time of listing. A 2023 study by the CFA Institute found that 92% of IPO issuers had fully constituted nominating and compensation committees by the first day of trading, compared to 41% of SPACs at the time of business combination.

Practical Implications for Hong Kong-Based Issuers

Director Recruitment Timelines and Costs

Hong Kong companies targeting a US listing through a traditional IPO typically need to recruit three to five independent directors with US public company experience, a process that takes 6 to 12 months and costs an estimated USD 150,000 to USD 300,000 in search fees, legal costs, and director compensation commitments. For a SPAC route, the target can negotiate with the SPAC’s existing board to retain some directors, potentially reducing recruitment costs by 40% to 60%. However, the 2025 Bulletin’s requirement for a pre-vote independence analysis means that any director who fails the reassessment must be replaced before the shareholder vote, compressing the timeline to 60 to 90 days.

Risk of Post-Combination Deficiency Letters

The SEC’s Division of Corporation Finance issued 22 deficiency letters to de-SPAC companies between January and June 2025, with 9 specifically citing board independence failures. The most common deficiency involved audit committee members who had received compensation from the sponsor during the pre-combination period, violating the fee prohibition in Rule 5605(c)(2)(A). For Hong Kong issuers, this risk is heightened because sponsor relationships often involve cross-border consulting agreements that may not be immediately apparent to the target’s due diligence team.

Actionable Takeaways for Issuers and Sponsors

1. For a traditional IPO, begin independent director recruitment at least 12 months before the anticipated S-1 filing date to ensure audit committee compliance and avoid SEC comment letters on governance disclosures.
2. For a SPAC transaction, conduct a full board independence audit at the time of the letter of intent, not at the proxy filing stage, to identify conflicts early and allow time for director replacement.
3. Ensure that any director who served on the SPAC board and has a relationship with the sponsor—including legal, consulting, or investment banking relationships—is evaluated under the operating company independence standard before the business combination vote.
4. Document all director independence determinations in writing, with specific reference to the applicable NASDAQ or NYSE rule section, and include this analysis in the proxy statement as required by the SEC’s March 2025 Bulletin.
5. Consider engaging a US-qualified independent governance advisor to conduct the independence review, particularly for Hong Kong issuers whose directors may have relationships with multiple cross-border entities that are not immediately apparent from a standard D&O questionnaire.